257 related articles for article (PubMed ID: 17304469)
21. Time to put boots on the ground: making universal access to MDR-TB treatment a reality.
Keshavjee S; Farmer PE
Int J Tuberc Lung Dis; 2010 Oct; 14(10):1222-5. PubMed ID: 20843411
[No Abstract] [Full Text] [Related]
22. XDR tuberculosis--implications for global public health.
Raviglione MC; Smith IM
N Engl J Med; 2007 Feb; 356(7):656-9. PubMed ID: 17301295
[No Abstract] [Full Text] [Related]
23. [Multidrug resistance tuberculosis - current problems].
Kruczak K; Nizankowska-Mogilnicka E
Pneumonol Alergol Pol; 2009; 77(3):276-83. PubMed ID: 19591099
[TBL] [Abstract][Full Text] [Related]
24. The clinical management of drug-resistant tuberculosis.
Furin J
Curr Opin Pulm Med; 2007 May; 13(3):212-7. PubMed ID: 17414129
[TBL] [Abstract][Full Text] [Related]
25. The impact of drug resistance on the global tuberculosis epidemic.
Schluger NW
Int J Tuberc Lung Dis; 2000 Feb; 4(2 Suppl 1):S71-5. PubMed ID: 10688153
[No Abstract] [Full Text] [Related]
26. The global threat of drug-resistant tuberculosis.
Snider DE; Castro KG
N Engl J Med; 1998 Jun; 338(23):1689-90. PubMed ID: 9614262
[No Abstract] [Full Text] [Related]
27. [Tuberculosis in Somalia with consequences in Sweden].
Winstrand A; Kulane A; von Schreeb J
Lakartidningen; 2010 Dec; 107(51-52):3279-81. PubMed ID: 21294349
[No Abstract] [Full Text] [Related]
28. Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis.
Gupta R; Espinal MA; Raviglione MC
Int J Tuberc Lung Dis; 2000 Nov; 4(11):1089-91. PubMed ID: 11092726
[No Abstract] [Full Text] [Related]
29. Extensively drug-resistant tuberculosis: new strains, new challenges.
Banerjee R; Schecter GF; Flood J; Porco TC
Expert Rev Anti Infect Ther; 2008 Oct; 6(5):713-24. PubMed ID: 18847407
[TBL] [Abstract][Full Text] [Related]
30. World Health Organization fact sheet. Tuberculosis.
World Health Organization
Saudi Med J; 2004 Aug; 25(8):1136-8. PubMed ID: 15457607
[No Abstract] [Full Text] [Related]
31. Rational 'DOTS plus' for the control of MDR-TB.
Espinal MA; Dye C; Raviglione M; Kochi A
Int J Tuberc Lung Dis; 1999 Jul; 3(7):561-3. PubMed ID: 10423218
[No Abstract] [Full Text] [Related]
32. Improving technical assistance for drug-resistant tuberculosis.
Furin J
Int J Tuberc Lung Dis; 2011 Mar; 15(3):421-2. PubMed ID: 21333116
[No Abstract] [Full Text] [Related]
33. Multidrug-resistant tuberculosis on Australia's northern border.
Simpson G
Intern Med J; 2011 Nov; 41(11):759-61. PubMed ID: 22077943
[No Abstract] [Full Text] [Related]
34. [Tuberculosis as an international and national problem].
Khomenko AG
Probl Tuberk; 1994; (2):2-4. PubMed ID: 8036208
[No Abstract] [Full Text] [Related]
35. Role of Treatment Cost on Transmission of Multidrug-Resistant Tuberculosis Into Iran.
Bialvaei AZ; Kafil HS; Asgharzadeh M
Clin Infect Dis; 2015 Sep; 61(6):1029-30. PubMed ID: 26060290
[No Abstract] [Full Text] [Related]
36. Trench warfare in a battle with TB.
Marshall E
Science; 2008 Jul; 321(5887):362-4. PubMed ID: 18635790
[No Abstract] [Full Text] [Related]
37. Estonia races to halt multidrug-resistant TB before HIV takes hold.
Lindsay M
Bull World Health Organ; 2002; 80(6):519. PubMed ID: 12132016
[No Abstract] [Full Text] [Related]
38. Multidrug-resistant tuberculosis (TB) resistant to fluoroquinolones and streptomycin but susceptible to second-line injection therapy has a better prognosis than extensively drug-resistant TB.
Chan ED; Strand MJ; Iseman MD
Clin Infect Dis; 2009 Mar; 48(5):e50-2. PubMed ID: 19191632
[TBL] [Abstract][Full Text] [Related]
39. World tuberculosis control: how far have we to go?
Enarson DA
Int J Tuberc Lung Dis; 2000 Dec; 4(12 Suppl 2):S219-23. PubMed ID: 11144556
[No Abstract] [Full Text] [Related]
40. Programmatic management of multidrug resistant TB.
Sarin R
Indian J Tuberc; 2009 Oct; 56(4):171-3. PubMed ID: 20469727
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
